Overview

Safety and Efficacy of Telapristone Acetate (Proellex®) in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis

Status:
Completed
Trial end date:
2017-03-15
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine the safety and efficacy of two oral doses of telapristone acetate administered to premenopausal women with pelvic pain associated with endometriosis confirmed within the last seven years and using prescription analgesics for symptomatic pain.
Phase:
Phase 2
Details
Lead Sponsor:
Repros Therapeutics Inc.